Staffing: 2024’s Biggest Lab Operations Challenge
ADLM president Anthony Killeen looks at labs’ staffing struggles in 2024 and what can be done to alleviate them in the coming year
Keeps You Up-to-Date on Lab Business and Competitive Strategy, Market Trends and Opportunities, and M&A and Investment Activity in Today’s Diagnostic Lab Industry
ADLM president Anthony Killeen looks at labs’ staffing struggles in 2024 and what can be done to alleviate them in the coming year
Senate committee members propose a modified version of legislation allowing the FDA to continue to regulate LDTs on a risk-tiered basis.
Companies will explore LabDroid’s capacity to automate sample preparation workflows for long-read sequencing systems.
Companies are using the lessons learned from COVID-19 to get out of the box quickly in developing test kits for monkeypox.
Most diagnostics companies experienced modest, flat, or negative top-line revenue growth rates in the first quarter of 2022.
In this month’s Business Roundup, we cover key happenings including Medicare coverage and reimbursement, as well as the US surpassing Europe as medtech’s market of choice.
Healthcare M&A might have bottomed out in the first quarter of 2022 in terms of both deal volume and size, according to a new report.
InspectIR COVID-19 device detects the virus from breath samples in less than three minutes, offering a new screening option.
The recently-formed Precision Cancer Consortium will make it easier for cancer patients around the world to get access to genomic testing.
The HHS recently published previously confidential data relating to consolidation of hospitals and nursing homes enrolled in Medicare.
The FDA has plans to ensure COVID-19 test makers won’t be left high and dry when the public health emergency ends.